PEN Penumbra
- 209.535
- +3.475+1.69%
Penumbra News
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
ALAMEDA, Calif., May 1, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Wed
Those Who Invested in Penumbra (NYSE:PEN) Five Years Ago Are up 56%
It hasn't been the best quarter for Penumbra, Inc. (NYSE:PEN) shareholders, since the share price has fallen 19% in that time. On the bright side the share price is up over the last half decade. U
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
Express News | Penumbra Announced The US Food And Drug Administration Clearance And Launch Of Lightning Flash 2.0 Designed To Rapidly Remove Blood Clots
Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots
Combined with streamlined audio-visual feedback, Lightning Flash 2.0 is designed to enable physicians to restore blood flow more quickly and further minimize blood loss
RBC Capital Sticks to Their Buy Rating for Penumbra (PEN)
Piper Sandler Remains a Buy on Penumbra (PEN)
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
ALAMEDA, Calif., April 9, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market clos
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE:ABT) over Penumbra, Inc. (NYSE: PEN). "I still fear it after the environmental damage. I am concerned th
Here's Why You Should Retain Penumbra (PEN) Stock for Now
The Returns At Penumbra (NYSE:PEN) Aren't Growing
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Ideally, a business will show two trends; firstly a growing
Top Buy-rated Stocks and Sell-rated Stocks Within Health Care - Citi
Insider Sell: EVP, General Counsel & Secretary Johanna Roberts Sells Shares of Penumbra Inc ...
Penumbra(PEN.US) Director Sells US$37,940.6 in Common Stock
$Penumbra(PEN.US)$ Director Kassing Don W. sold 170 shares of Common Stock on Apr 1, 2024 at an average price of $223.18 for a total value of $37,940.6.Source: Announcement What is statement of change
Penumbra(PEN.US) Officer Sells US$130.24K in Common Stock
$Penumbra(PEN.US)$ Officer Roberts Johanna sold 600 shares of Common Stock on Apr 1, 2024 at an average price of $217.07 for a total value of $130.24K.Source: Announcement What is statement of changes
Penumbra Price Target Maintained With a $290.00/Share by Piper Sandler
Penumbra Price Target Maintained With a $290.00/Share by Piper Sandler
Express News | Piper Sandler Reiterates Overweight on Penumbra, Maintains $290 Price Target
J&J-Shockwave Deal Makes Strategic Sense: Analysts
Penumbra Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
In the preceding three months, 8 analysts have released ratings for Penumbra (NYSE:PEN), presenting a wide array of perspectives from bullish to bearish.The following table provides a quick overview o
Penumbra Is Maintained at Buy by Truist Securities
Penumbra Is Maintained at Buy by Truist Securities
Analysis
Price Target
No Data
